Q3 2025 Holdings
Filed 2025-11-14 | 12 holdings | $22.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Rezolute Inc(RZLT) | COM NEW | 76200L309 | $18.7M | 1,986,818 | 81.7% |
| Spdr Gold TR(GLD) | GOLD SHS | 78463V107 | $2.6M | 7,286 | 11.3% |
| Berkshire Hathaway Inc del(BRK/B) | CL B NEW | 084670702 | $327.5K | 651 | 1.4% |
| Mind Medicine Mindmed Inc(BRD1EUR) | COM NEW | 60255C885 | $318.5K | 27,011 | 1.4% |
| Enliven Therapeutics Inc(ELVN) | COM | 29337E102 | $268.1K | 13,097 | 1.2% |
| Compass Therapeutics Inc(CMPX) | COM | 20454B104 | $187.3K | 53,503 | 0.8% |
| Bicara Therapeutics Inc(BCAX) | COM | 055477103 | $172.8K | 10,941 | 0.8% |
| Kyverna Therapeutics Inc(KYTX) | COM | 501976104 | $137.9K | 22,981 | 0.6% |
| Lexeo Therapeutics Inc(LXEO) | COM | 52886X107 | $115.1K | 17,332 | 0.5% |
| Inhibikase Therapeutics Inc(IKT) | COM NEW | 45719W205 | $26.6K | 16,393 | 0.1% |
| SAB Biotherapeutics Inc(SABS) | COM NEW | 78397T202 | $22.0K | 10,935 | 0.1% |
| Context Therapeutics Inc(CNTX) | COM | 21077P108 | $17.8K | 18,403 | 0.1% |